학술논문

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Document Type
Letter
Source
Egyptian Heart Journal; 5/18/2020, Vol. 72 Issue 1, p1-6, 6p
Subject
Language
ISSN
11102608